JSA/WAO Joint Congress 2020

Presentation information

Poster Session

ENT

[PE23] Poster Session 23
Immunotherapy 2

[PE23-4] Development of a novel Cry j 1 allergoid using chemical modification

Takeru Sugawara, Keisuke Suzuki, Fujinami Koji, Katsuyo Ohashi-Doi (Research Laboratory, Torii Pharmaceutical Co., Ltd, Japan)

The password to see abstracts was announced to registrants by email.

Password